Your browser doesn't support javascript.
loading
Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinoma.
Shimizu, Kazuki; Tamada, Satoshi; Matsuoka, Yudai; Go, Ishun; Okumura, Satoshi; Ogawa, Masao; Ohmachi, Tetsuji.
Afiliação
  • Shimizu K; Department of Urology, Bell Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai City, Osaka 599-8247 Japan.
  • Tamada S; Department of Urology, Bell Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai City, Osaka 599-8247 Japan.
  • Matsuoka Y; Department of Urology, Bell Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai City, Osaka 599-8247 Japan.
  • Go I; Department of Urology, Bell Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai City, Osaka 599-8247 Japan.
  • Okumura S; Department of Surgery, Bell Land General Hospital, Sakai City, Japan.
  • Ogawa M; Department of Surgery, Bell Land General Hospital, Sakai City, Japan.
  • Ohmachi T; Department of Urology, Bell Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai City, Osaka 599-8247 Japan.
Int Cancer Conf J ; 11(3): 205-209, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35669898
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Cancer Conf J Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Cancer Conf J Ano de publicação: 2022 Tipo de documento: Article